DotBio logo

DotBio

DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit www.dotbiopharma.com

Free account • No credit card • 5 profiles/day

Biotechnology Research 21 Employees Found Singapore Founded 2018 30276 Similar Companies
21 Employees Found
86% Email Coverage
$4.7M Est Revenue
1 Office HQ
30276 Similar Companies

Frequently asked questions about DotBio

What is DotBio email format?

The widely used DotBio email format is {first_initial}{last} (e.g. jsmith@dotbiopharma.com) with 75.00% adoption across the company.

What is DotBio customer service number?

To contact DotBio customer service number in your country click here to find.